Searched for
NATCO PHARMA STOCKS
Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...- Ahead of Market: 10 things that will decide stock market action on TuesdayBenchmark indices Sensex and Nifty fell for a fourth straight session amid elevated crude oil prices, geopolitical tensions and persistent ...
- Bearish move or buying opportunity? Geojit's Anand James on Nifty levels and top stocks to watchMarket volatility surged following a late-Friday sell-off, with MSCI rebalancing and global cues cited as triggers. Geojit Financial Servic...
- Ahead of Market: 10 things that will decide stock market action on MondayIndian equity markets ended sharply lower on May 29 amid broad-based selling, MSCI-driven flows and rising volatility. Technical indicators...
- Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoYNatco Pharma shares plunged after the company reported a steep fall in fourth-quarter profit, revenue and EBITDA. Weak operating margins an...
- Holding stocks is harder than finding them: 10 mid- and small-caps stocks that may be worth holding on toHolding a stock is not an act of blind faith. It is not refusing to change one’s mind. It is not averaging down because the stock has falle...
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
- JioBlackRock Flexi Cap Fund exits Swiggy, 20 other stocks; adds ICICI Pru AMC and 9 more in MarchJioBlackRock Mutual Fund’s Flexi Cap Fund exited Swiggy and 20 other stocks in March, while adding ICICI Prudential Asset Management Compan...
- Stock Radar: Natco Pharma stock shows rounding bottom formation; should you buy the stock for long term?Natco Pharma is trading above the neckline of a rounding bottom formation, suggesting a bullish outlook. Experts recommend buying for a tar...
- Natco Pharma shares jump over 5% after three-day slumpNatco Pharma shares surged on Wednesday, bouncing back from a three-day decline that followed a US FDA inspection of its API manufacturing ...
- Stock Radar: Natco Pharma stock showing signs of momentum after falling over 30% from highs – what should investors do?Natco Pharma Ltd, a player in the pharma industry, has exhibited a bullish breakout from an Ascending Triangle pattern, hinting at potentia...
- Add Natco Pharma, target price Rs 1145: ICICI SecuritiesNatco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 18515.48 Crore) operating in Pharmaceutic...
- Accumulate Natco Pharma, target price Rs 1116: Geojit Financial ServicesNatco Pharma, incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 17460.53 crore) operating in pharmaceuticals s...
- Add Natco Pharma, target price Rs 875: ICICI SecuritiesNatco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 13863.10 Crore) operating in Pharmaceutic...
- Natco Pharma approves Rs 210 cr-share buyback; stock risesThe buyback proposal will not exceed the maximum size, which represents 5.13% and 5.04% of the aggregate of the total paid-up capital and f...
- Buy Natco Pharma, target price Rs 704: Geojit Financial ServicesNatco Pharma, incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 10573.71 Crore) operating in Pharmaceuticals s...
- Hold Natco Pharma, target price Rs 660: ICICI DirectNatco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 10403.02 Crore) operating in Pharmaceutic...
- Natco Pharma rises 4% on receiving court order to launch ChlorantraniliproleNatco is the first company in India to have received its registration approval given by the Central Insecticide Board & Registration Commit...
- Natco Pharma a buy: Ashwani Gujral, StrategistThe pharma midcaps are likely to do well.
Load More
